Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


5 Am J Hypertens
1 Hypertension
1 J Cardiovasc Pharmacol
2 J Hypertens
8 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Hypertens

  1. REGES O, Krefman AE, Hardy ST, Yano Y, et al
    Decision Tree-Based Classification for Maintaining Normal Blood Pressure Throughout Early Adulthood and Middle Age: Findings From the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Am J Hypertens. 2021;34:1037-1041.
    PubMed         Abstract available

  2. KABAYAMA M, Akagi Y, Wada N, Higuchi A, et al
    A Randomized Trial of Home Blood-Pressure Reduction by Alcohol Guidance During Outpatient Visits: OSAKE Study.
    Am J Hypertens. 2021;34:1108-1115.
    PubMed         Abstract available

  3. MATSUOKA S, Kaneko H, Yano Y, Itoh H, et al
    Association Between Blood Pressure Classification Using the 2017 ACC/AHA Blood Pressure Guideline and Retinal Atherosclerosis.
    Am J Hypertens. 2021;34:1049-1056.
    PubMed         Abstract available

    From the Editor-in-Chief: Issue at a Glance.
    Am J Hypertens. 2021;34:123-124.

  5. BAKHOUM CY, Anderson CAM, Juraschek SP, Rebholz CM, et al
    The Relationship Between Urine Uromodulin and Blood Pressure Changes: The DASH-Sodium Trial.
    Am J Hypertens. 2021;34:154-156.
    PubMed         Abstract available


  6. BRYANT KB, Green MB, Shimbo D, Schwartz JE, et al
    Home Blood Pressure Monitoring for Hypertension Diagnosis by Current Recommendations: A Long Way to Go.
    Hypertension. 2021 Dec 2:HYPERTENSIONAHA12118463.

    J Cardiovasc Pharmacol

  7. TEMIZ-RESITOGLU M, Guden DS, Senol SP, Vezir O, et al
    Pharmacological inhibition of mTOR attenuates DOCA-salt-induced hypertension and related pathophysiology: regulation of oxidative stress, inflammation and cardiovascular hypertrophy in male rats.
    J Cardiovasc Pharmacol. 2021 Nov 23. pii: 00005344-900000000-98105.
    PubMed         Abstract available

    J Hypertens

  8. BATTA D, Korosi B, Gyongyosi H, Nemcsik-Bencze Z, et al
    Cross-sectional comparison of office and ambulatory pulse wave velocity by two methods, and their changes after lifestyle or medical interventions in hypertension.
    J Hypertens. 2021 Nov 26. pii: 00004872-900000000-96534.
    PubMed         Abstract available

  9. THANGARAJ SS, Oxlund CS, Fonseca MPD, Svenningsen P, et al
    The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-[gamma] and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension.
    J Hypertens. 2021 Aug 23. pii: 00004872-900000000-96579.
    PubMed         Abstract available

    PLoS One

  10. ANH HIEN H, Tam NM, Tam V, Van Minh H, et al
    Correction: Estimation of the cardiovascular risk using world health organization/international society of hypertension risk prediction charts in Central Vietnam.
    PLoS One. 2021;16:e0261099.
    PubMed         Abstract available

  11. CHOWDHURY MAB, Islam M, Rahman J, Uddin MT, et al
    Changes in prevalence and risk factors of hypertension among adults in Bangladesh: An analysis of two waves of nationally representative surveys.
    PLoS One. 2021;16:e0259507.
    PubMed         Abstract available

  12. SCIME NV, Hetherington E, Tomfohr-Madsen L, Nettel-Aguirre A, et al
    Hypertensive disorders in pregnancy and child development at 36 months in the All Our Families prospective cohort study.
    PLoS One. 2021;16:e0260590.
    PubMed         Abstract available

  13. BOONYATHEE S, Seangpraw K, Ong-Artborirak P, Auttama N, et al
    Effects of a social support family caregiver training program on changing blood pressure and lipid levels among elderly at risk of hypertension in a northern Thai community.
    PLoS One. 2021;16:e0259697.
    PubMed         Abstract available

  14. LEADER CJ, Wilkins GT, Walker RJ
    The effect of spironolactone on cardiac and renal fibrosis following myocardial infarction in established hypertension in the transgenic Cyp1a1Ren2 rat.
    PLoS One. 2021;16:e0260554.
    PubMed         Abstract available

  15. ASANO R, Ogo T, Morita Y, Kotoku A, et al
    Prognostic value of right ventricular native T1 mapping in pulmonary arterial hypertension.
    PLoS One. 2021;16:e0260456.
    PubMed         Abstract available

  16. SHIN J, Konlan KD, Mensah E
    Health promotion interventions for the control of hypertension in Africa, a systematic scoping review from 2011 to 2021.
    PLoS One. 2021;16:e0260411.
    PubMed         Abstract available

  17. SHRESTHA N, Gautam S, Mishra SR, Virani SS, et al
    Burden of chronic kidney disease in the general population and high-risk groups in South Asia: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0258494.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.